• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波斯尼亚和黑塞哥维那 COVID-19 大流行的头两个月:单中心经验。

The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.

机构信息

Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina; Faculty of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina.

出版信息

Bosn J Basic Med Sci. 2020 Aug 3;20(3):396-400. doi: 10.17305/bjbms.2020.4838.

DOI:10.17305/bjbms.2020.4838
PMID:32464084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7416183/
Abstract

The novel coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still progressing and has been recorded in more than 210 countries and territories worldwide. In Bosnia and Herzegovina, the first cases of COVID- 19 were detected on March 5, 2020 in the entity of the Republic of Srpska and on March 9, 2020 in the entity of the Federation of Bosnia and Herzegovina. By May 16, 2020, more than 2,200 COVID-19 cases had been recorded in both entities, with a mortality rate of 5.8% (131 of 2,231 cases). The aim of this ongoing study is to present the current epidemiological and sociodemographic parameters of 380 COVID-19 patients diagnosed at the University Clinical Hospital Mostar (UCH Mostar) during the first two months of the COVID-19 pandemic. Of those 380 patients, 60 (15.8%) required hospitalization. The mortality rate was 5% (19/380). The highest mortality rate (15.2%, 12/79) was recorded in the patients aged ≥65 years. In addition to this single-center experience of the ongoing COVID-19 pandemic, we discuss the epidemiological mea-sures imposed in Bosnia and Herzegovina, with an emphasis on the restrictive measures. The COVID-19 pandemic is still ongoing in Bosnia and Herzegovina.

摘要

2019 年新型冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的大流行,目前已在全球 210 多个国家和地区记录。在波斯尼亚和黑塞哥维那,COVID-19 首例病例于 2020 年 3 月 5 日在塞族共和国实体中被发现,2020 年 3 月 9 日在波斯尼亚和黑塞哥维那联邦实体中被发现。截至 2020 年 5 月 16 日,两个实体中记录的 COVID-19 病例已超过 2200 例,死亡率为 5.8%(2231 例中有 131 例)。本研究旨在介绍 COVID-19 大流行的头两个月在莫斯塔尔大学临床医院(UCH Mostar)诊断的 380 例 COVID-19 患者的当前流行病学和社会人口统计学参数。在这 380 名患者中,有 60 名(15.8%)需要住院治疗。死亡率为 5%(19/380)。年龄≥65 岁的患者死亡率最高(15.2%,12/79)。除了介绍这一单一中心在 COVID-19 大流行期间的经验外,我们还讨论了波斯尼亚和黑塞哥维那实施的流行病学措施,重点讨论了限制性措施。COVID-19 大流行在波斯尼亚和黑塞哥维那仍在继续。

相似文献

1
The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.波斯尼亚和黑塞哥维那 COVID-19 大流行的头两个月:单中心经验。
Bosn J Basic Med Sci. 2020 Aug 3;20(3):396-400. doi: 10.17305/bjbms.2020.4838.
2
Overview of Early Cases of Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Centre in North India.印度北部一家三级护理中心 2019 年冠状病毒病(COVID-19)早期病例概述。
Ann Acad Med Singap. 2020 Jul;49(7):449-455.
3
Determinants of the COVID-19 Pandemic in the West Herzegovina Canton.西黑塞哥维那州新冠疫情的决定因素。
Psychiatr Danub. 2020 Sep;32(Suppl 2):221-225.
4
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
5
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.中国浙江省 465 例新冠肺炎(COVID-19)住院病例的流行病学、临床和病毒学特征。
Influenza Other Respir Viruses. 2020 Sep;14(5):564-574. doi: 10.1111/irv.12758. Epub 2020 May 19.
6
Pediatric patients with benign hematological diseases during the COVID-19 pandemic.新冠疫情期间患有良性血液病的儿科患者。
Pediatr Blood Cancer. 2020 Sep;67(9):e28595. doi: 10.1002/pbc.28595. Epub 2020 Jul 15.
7
Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.基于西班牙急诊科收治的 1000 例患者系列,分析 COVID-19 患者的临床特征和结局。
Emergencias. 2020;32(4):233-241.
8
Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample.斯洛文尼亚新冠病毒活跃感染率低:基于概率抽样的全国人口研究。
Clin Microbiol Infect. 2020 Nov;26(11):1514-1519. doi: 10.1016/j.cmi.2020.07.013. Epub 2020 Jul 18.
9
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
10
Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection.由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染引起的儿童冠状病毒病(COVID-19)病例所呈现出的经验教训。
Pediatr Pulmonol. 2020 May;55(5):1085-1086. doi: 10.1002/ppul.24748. Epub 2020 Apr 3.

引用本文的文献

1
Excess All-Cause Mortality by Age and Gender During the COVID-19 Pandemic in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina: 2020-2022.2020 - 2022年波斯尼亚和黑塞哥维那联邦在新冠疫情期间按年龄和性别的全因死亡率过高情况,波斯尼亚和黑塞哥维那
Influenza Other Respir Viruses. 2025 Mar;19(3):e70086. doi: 10.1111/irv.70086.
2
Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers.与医护人员使用个人防护装备相关的新冠病毒抗体血清流行率
Mater Sociomed. 2024;36(3):222-228. doi: 10.5455/msm.2024.36.222-228.
3
Changes in management of head and neck malignancies during the COVID-19 pandemic.COVID-19 大流行期间头颈部恶性肿瘤的治疗管理变化。
Acta Otorhinolaryngol Ital. 2024 Jun;44(3):169-175. doi: 10.14639/0392-100X-N2779. Epub 2024 Apr 30.
4
COVID-19 Seroprevalence in Children during Pandemic Waves in Sarajevo, a Single Center Experience.COVID-19 血清流行率在萨拉热窝大流行波期间的儿童中,单一中心经验。
Acta Med Acad. 2023 Apr;52(1):56-62. doi: 10.5644/ama2006-124.403.
5
Family Physicians' Perceptions of Primary Health Care Use in Bosnia and Herzegovina during the Covid-19 Pandemic, a Cross-sectional Study.家庭医生在新冠疫情期间对波黑初级卫生保健使用的看法:一项横断面研究。
Acta Med Acad. 2023 Apr;52(1):13-23. doi: 10.5644/ama2006-124.397.
6
COVID-19 in the Federation of Bosnia and Herzegovina: Strengthening the public health surveillance using a web-based system to inform public health response, March 2020 - March 2022.波斯尼亚和黑塞哥维那联邦的 COVID-19 疫情:利用基于网络的系统加强公共卫生监测,为公共卫生应对提供信息,2020 年 3 月至 2022 年 3 月。
Biomol Biomed. 2023 Jul 3;23(4):718-725. doi: 10.17305/bb.2022.8050.
7
Characteristics and Outcomes of Critically Ill Pregnant/Postpartum Women with COVID-19 Pneumonia in Western Balkans, The Republic of Srpska Report.西巴尔干地区斯普斯卡共和国报告:COVID-19 肺炎危重症孕妇/产后女性的特征和结局。
Medicina (Kaunas). 2022 Nov 26;58(12):1730. doi: 10.3390/medicina58121730.
8
Dose Descriptors and Assessment of Risk of Exposure-Induced Death in Patients Undergoing COVID-19 Related Chest Computed Tomography.新冠病毒肺炎相关胸部计算机断层扫描患者的剂量描述符与暴露诱导死亡风险评估
Diagnostics (Basel). 2022 Aug 19;12(8):2012. doi: 10.3390/diagnostics12082012.
9
Does pre-existing immunity determine the course of SARS-CoV-2 infection in health-care workers? Single-center experience.预先存在的免疫是否决定了医护人员中 SARS-CoV-2 感染的过程?单中心经验。
Infection. 2023 Apr;51(2):323-330. doi: 10.1007/s15010-022-01859-y. Epub 2022 Jun 13.
10
Acceptance, effects, and tolerability in the vaccination process against SARS-CoV-2 among cancer patients in Bosnia and Herzegovina: A single-center cross-sectional study.在波斯尼亚和黑塞哥维那,癌症患者对 SARS-CoV-2 疫苗接种过程中的接受度、效果和耐受性:一项单中心横断面研究。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):833-842. doi: 10.17305/bjbms.2021.7134.

本文引用的文献

1
Short epidemiological overview of the current situation on COVID-19 pandemic in Southeast European (SEE) countries.东南欧(SEE)国家新冠疫情现状的简短流行病学概述。
J Infect Dev Ctries. 2020 May 31;14(5):433-437. doi: 10.3855/jidc.12814.
2
Assessing the effects of metropolitan-wide quarantine on the spread of COVID-19 in public space and households.评估全市范围的隔离措施对公共空间和家庭中 COVID-19 传播的影响。
Int J Infect Dis. 2020 Jul;96:503-505. doi: 10.1016/j.ijid.2020.05.019. Epub 2020 May 8.
3
Lessons learned from COVID-19 pandemic in Italy - A commentary.从意大利 COVID-19 大流行中吸取的教训——评论。
Bosn J Basic Med Sci. 2021 Feb 1;21(1):117-119. doi: 10.17305/bjbms.2020.4847.
4
Case Fatality Risk of the First Pandemic Wave of Coronavirus Disease 2019 (COVID-19) in China.中国2019年冠状病毒病(COVID-19)第一波大流行的病死率
Clin Infect Dis. 2021 Jul 1;73(1):e79-e85. doi: 10.1093/cid/ciaa578.
5
Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK.量化身体距离措施对英国 COVID-19 传播的影响。
BMC Med. 2020 May 7;18(1):124. doi: 10.1186/s12916-020-01597-8.
6
Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies.四大洲 COVID-19 呈幂律增长与软性隔离策略效率低下之间存在很强的相关性。
Chaos. 2020 Apr;30(4):041102. doi: 10.1063/5.0009454.
7
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.伴有糖尿病的重症 COVID-19 患者的临床特征和结局。
BMJ Open Diabetes Res Care. 2020 Apr;8(1). doi: 10.1136/bmjdrc-2020-001343.
8
The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou.温州新型冠状病毒感染(COVID-19)无症状感染者的临床特征
J Med Virol. 2020 Oct;92(10):1761-1763. doi: 10.1002/jmv.25861. Epub 2020 Jun 16.
9
Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China.中国武汉 102 例 2019 年冠状病毒病患者的临床特征和短期预后。
Clin Infect Dis. 2020 Jul 28;71(15):748-755. doi: 10.1093/cid/ciaa243.
10
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.